Selective synthesis of 13-epi-manoyl oxide
Închide
Articolul precedent
Articolul urmator
734 13
Ultima descărcare din IBN:
2023-05-28 04:01
Căutarea după subiecte
similare conform CZU
547:577:576 (1)
Chimie organică (475)
Bazele materiale ale vieții. Biochimie. Biologie moleculară. Biofizică (657)
Biologie celulară și subcelulară. Citologie (129)
SM ISO690:2012
MORĂRESCU (CHETRARU), Olga, TRAISTARI, Marionela, BARBA, Alic, DUKA, Gh., UNGUR, Nikon, KULCIŢKI, Veaceslav. Selective synthesis of 13-epi-manoyl oxide. In: New frontiers in natural product chemistry.: A destiny on the altar of research. Dedicated to academician Pavel Vlad, Ed. 6, 21 mai 2021, Chișinău. Chișinău, Republica Moldova: Tipografia "Artpoligraf", 2021, Ediția 6, p. 34. ISBN 978-9975-3336-7-2. DOI: https://doi.org/10.19261/nfnpc.2021.ab27
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
New frontiers in natural product chemistry.
Ediția 6, 2021
Conferința " New frontiers in natural product chemistry."
6, Chișinău, Moldova, 21 mai 2021

Selective synthesis of 13-epi-manoyl oxide

DOI: https://doi.org/10.19261/nfnpc.2021.ab27
CZU: 547:577:576

Pag. 34-34

Morărescu (Chetraru) Olga1, Traistari Marionela2, Barba Alic1, Duka Gh.1, Ungur Nikon1, Kulciţki Veaceslav1
 
1 Institute of Chemistry,
2 Moldova State University
 
Proiecte:
 
Disponibil în IBN: 28 mai 2021


Rezumat

Labdane-type diterpenes are excellent examples of natural products with important pharmaceutical activities. Besides, several labdanes are quite abundant in nature and/or are commercially, such as sclareol 1. Hence, they are useful starting materials for chemical transformations. On the other hand, manoyl oxide 2 and 13-epi-manoyl oxide 3 are labdane compounds with skeleton identical to forskolin – a secondary metabolite isolated from Coleus forskohlii plant and showing a myriad of therapeutic activities [1], and other relevant natural compounds reported in structure-activity relationship (SAR) [2,3]. We have also demonstrated recently a free-radical procedure for structural modification of both forskolin and manoyl oxides [4,5] leading to an unusual distal functionalization of 13-epi- framework. In order to explore the full potential of such late-stage functionalization, one needs reliable sources of 13-epi-manoyl oxide 3, which ideally is made available via selective synthesis. The current work presents the selective one-step synthesis of 13-epi-manoyl oxide 3 basing on a low-temperature superacidic cyclization of sclareol 1 (Scheme 1). An older contribution of some of us reported an equimolar mixture of epimers [6]. Now, the reaction conditions have been finely tuned in order to achieve a 9:1 ratio in favor of the desired 13-epioxide 3. The preparative value of the elaborated procedure was convincingly demonstrated. Scheme 1

Cerif XML Export

<?xml version='1.0' encoding='utf-8'?>
<CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'>
<cfResPubl>
<cfResPublId>ibn-ResPubl-131137</cfResPublId>
<cfResPublDate>2021</cfResPublDate>
<cfVol>Ediția 6</cfVol>
<cfStartPage>34</cfStartPage>
<cfISBN>978-9975-3336-7-2</cfISBN>
<cfURI>https://ibn.idsi.md/ro/vizualizare_articol/131137</cfURI>
<cfTitle cfLangCode='EN' cfTrans='o'>Selective synthesis of 13-epi-manoyl oxide</cfTitle>
<cfAbstr cfLangCode='EN' cfTrans='o'><p>Labdane-type diterpenes are excellent examples of natural products with important pharmaceutical activities. Besides, several labdanes are quite abundant in nature and/or are commercially, such as sclareol 1. Hence, they are useful starting materials for chemical transformations. On the other hand, manoyl oxide 2 and 13-epi-manoyl oxide 3 are labdane compounds with skeleton identical to forskolin &ndash; a secondary metabolite isolated from Coleus forskohlii plant and showing a myriad of therapeutic activities [1], and other relevant natural compounds reported in structure-activity relationship (SAR) [2,3]. We have also demonstrated recently a free-radical procedure for structural modification of both forskolin and manoyl oxides [4,5] leading to an unusual distal functionalization of 13-epi- framework. In order to explore the full potential of such late-stage functionalization, one needs reliable sources of 13-epi-manoyl oxide 3, which ideally is made available via selective synthesis. The current work presents the selective one-step synthesis of 13-epi-manoyl oxide 3 basing on a low-temperature superacidic cyclization of sclareol 1 (Scheme 1). An older contribution of some of us reported an equimolar mixture of epimers [6]. Now, the reaction conditions have been finely tuned in order to achieve a 9:1 ratio in favor of the desired 13-epioxide 3. The preparative value of the elaborated procedure was convincingly demonstrated. Scheme 1</p></cfAbstr>
<cfResPubl_Class>
<cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfResPubl_Class>
<cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId>
<cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId>
<cfStartDate>2021T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfPers_ResPubl>
<cfPersId>ibn-person-12492</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-69213</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-11134</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-137</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-672</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-12140</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2021T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfFedId>
<cfFedIdId>ibn-doi-131137</cfFedIdId>
<cfFedId>10.19261/nfnpc.2021</cfFedId>
<cfStartDate>2021T24:00:00</cfStartDate>
<cfFedId_Class>
<cfClassId>31d222b4-11e0-434b-b5ae-088119c51189</cfClassId>
<cfClassSchemeId>bccb3266-689d-4740-a039-c96594b4d916</cfClassSchemeId>
</cfFedId_Class>
<cfFedId_Srv>
<cfSrvId>5123451</cfSrvId>
<cfClassId>eda2b2e2-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>5a270628-f593-4ff4-a44a-95660c76e182</cfClassSchemeId>
</cfFedId_Srv>
</cfFedId>
</cfResPubl>
<cfPers>
<cfPersId>ibn-Pers-12492</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-12492-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2021T24:00:00</cfStartDate>
<cfFamilyNames>Морареску</cfFamilyNames>
<cfFirstNames>Ольга</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-69213</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-69213-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2021T24:00:00</cfStartDate>
<cfFamilyNames>Traistari</cfFamilyNames>
<cfFirstNames>Marionela</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-11134</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-11134-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2021T24:00:00</cfStartDate>
<cfFamilyNames>Barba</cfFamilyNames>
<cfFirstNames>Alic</cfFirstNames>
<cfFamilyNames>Барба</cfFamilyNames>
<cfFirstNames>Алик</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-137</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-137-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2021T24:00:00</cfStartDate>
<cfFamilyNames>Duka</cfFamilyNames>
<cfFirstNames>Gh.</cfFirstNames>
<cfFamilyNames>Дука</cfFamilyNames>
<cfFirstNames>Георгий</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-672</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-672-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2021T24:00:00</cfStartDate>
<cfFamilyNames>Ungur</cfFamilyNames>
<cfFirstNames>Nikon</cfFirstNames>
<cfFamilyNames>Унгур</cfFamilyNames>
<cfFirstNames>Никон</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-12140</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-12140-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2021T24:00:00</cfStartDate>
<cfFamilyNames>Kulciţki</cfFamilyNames>
<cfFirstNames>Veaceslav</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfSrv>
<cfSrvId>5123451</cfSrvId>
<cfName cfLangCode='en' cfTrans='o'>CrossRef DOI prefix service</cfName>
<cfDescr cfLangCode='en' cfTrans='o'>The service of issuing DOI prefixes to publishers</cfDescr>
<cfKeyw cfLangCode='en' cfTrans='o'>persistent identifier; Digital Object Identifier</cfKeyw>
</cfSrv>
</CERIF>